Cargando…
Is there any relationship between mutation in CPS1 Gene and pregnancy loss?
BACKGROUND: Carbamoyl phosphate synthetase 1 (CPS1) is a liver-specific enzyme with the lowest enzymatic rate, which determines the overall rate of the other reactions in the pathway that converts ammonia to carbamoyl phosphate in the first step of the urea cycle. Carbamoyl phosphate synthetase 1 de...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Knowledge E
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653490/ https://www.ncbi.nlm.nih.gov/pubmed/31435610 http://dx.doi.org/10.18502/ijrm.v17i5.4604 |
_version_ | 1783438590950244352 |
---|---|
author | Talebi, Mehrdad Yahya Vahidi Mehrjardi, Mohammad Kalhor, Kambiz Dehghani, Mohammadreza |
author_facet | Talebi, Mehrdad Yahya Vahidi Mehrjardi, Mohammad Kalhor, Kambiz Dehghani, Mohammadreza |
author_sort | Talebi, Mehrdad |
collection | PubMed |
description | BACKGROUND: Carbamoyl phosphate synthetase 1 (CPS1) is a liver-specific enzyme with the lowest enzymatic rate, which determines the overall rate of the other reactions in the pathway that converts ammonia to carbamoyl phosphate in the first step of the urea cycle. Carbamoyl phosphate synthetase 1 deficiency (CPS1D), which usually presents as lethal hyperammonemia, is a rare autosomal recessive hereditary disease. CASE: We report a case of a two-day-old female neonate with lethal hyperammonemia. The newborn infant was presented with hyperammonemia (34.7 [Formula: see text] g/ml; reference range 1.1–1.9). In Plasma amino acid analysis, there was a significant elevated levels of alanine (3,004 [Formula: see text] mol/L; reference range, 236–410 [Formula: see text] mol/L), glutamine (2,256 [Formula: see text] mol/L; reference range, 20–107 [Formula: see text] mol/L), asparagine (126 [Formula: see text] mol/L; reference range, 30–69 [Formula: see text] mol/L), glutamic acid (356 [Formula: see text] mol/L; reference range, 14–192 [Formula: see text] mol/L), aspartic acid (123 [Formula: see text] mol/L; reference range, 0–24 [Formula: see text] mol/L), and lysine (342 [Formula: see text] mol/L; reference range, 114–269 [Formula: see text] mol/L). We cannot diagnose the urea cycle disorder (UCD) CPS1D properly only based on the quantity of biochemical intermediary metabolites to exclude other UCDs with similar symptoms. Following next generation sequencing determined one homozygous mutation in CPS1 gene and also this mutation was determined in her parents. The identified mutation was c.2758G [Formula: see text] C; p.Asp920His, in the 23 exon of CPS1. This novel homozygous mutation had not been reported previously. CONCLUSION: We applied whole exome sequencing successfully to diagnose the patient with CPS1D in a clinical setting. This result supports the clinical applicability of whole exome sequencing for cost-effective molecular diagnosis of UCDs. |
format | Online Article Text |
id | pubmed-6653490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Knowledge E |
record_format | MEDLINE/PubMed |
spelling | pubmed-66534902019-08-21 Is there any relationship between mutation in CPS1 Gene and pregnancy loss? Talebi, Mehrdad Yahya Vahidi Mehrjardi, Mohammad Kalhor, Kambiz Dehghani, Mohammadreza Int J Reprod Biomed Case Report BACKGROUND: Carbamoyl phosphate synthetase 1 (CPS1) is a liver-specific enzyme with the lowest enzymatic rate, which determines the overall rate of the other reactions in the pathway that converts ammonia to carbamoyl phosphate in the first step of the urea cycle. Carbamoyl phosphate synthetase 1 deficiency (CPS1D), which usually presents as lethal hyperammonemia, is a rare autosomal recessive hereditary disease. CASE: We report a case of a two-day-old female neonate with lethal hyperammonemia. The newborn infant was presented with hyperammonemia (34.7 [Formula: see text] g/ml; reference range 1.1–1.9). In Plasma amino acid analysis, there was a significant elevated levels of alanine (3,004 [Formula: see text] mol/L; reference range, 236–410 [Formula: see text] mol/L), glutamine (2,256 [Formula: see text] mol/L; reference range, 20–107 [Formula: see text] mol/L), asparagine (126 [Formula: see text] mol/L; reference range, 30–69 [Formula: see text] mol/L), glutamic acid (356 [Formula: see text] mol/L; reference range, 14–192 [Formula: see text] mol/L), aspartic acid (123 [Formula: see text] mol/L; reference range, 0–24 [Formula: see text] mol/L), and lysine (342 [Formula: see text] mol/L; reference range, 114–269 [Formula: see text] mol/L). We cannot diagnose the urea cycle disorder (UCD) CPS1D properly only based on the quantity of biochemical intermediary metabolites to exclude other UCDs with similar symptoms. Following next generation sequencing determined one homozygous mutation in CPS1 gene and also this mutation was determined in her parents. The identified mutation was c.2758G [Formula: see text] C; p.Asp920His, in the 23 exon of CPS1. This novel homozygous mutation had not been reported previously. CONCLUSION: We applied whole exome sequencing successfully to diagnose the patient with CPS1D in a clinical setting. This result supports the clinical applicability of whole exome sequencing for cost-effective molecular diagnosis of UCDs. Knowledge E 2019-06-26 /pmc/articles/PMC6653490/ /pubmed/31435610 http://dx.doi.org/10.18502/ijrm.v17i5.4604 Text en Copyright © 2019 Mehrdad Talebi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Case Report Talebi, Mehrdad Yahya Vahidi Mehrjardi, Mohammad Kalhor, Kambiz Dehghani, Mohammadreza Is there any relationship between mutation in CPS1 Gene and pregnancy loss? |
title | Is there any relationship between mutation in CPS1 Gene and pregnancy loss? |
title_full | Is there any relationship between mutation in CPS1 Gene and pregnancy loss? |
title_fullStr | Is there any relationship between mutation in CPS1 Gene and pregnancy loss? |
title_full_unstemmed | Is there any relationship between mutation in CPS1 Gene and pregnancy loss? |
title_short | Is there any relationship between mutation in CPS1 Gene and pregnancy loss? |
title_sort | is there any relationship between mutation in cps1 gene and pregnancy loss? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653490/ https://www.ncbi.nlm.nih.gov/pubmed/31435610 http://dx.doi.org/10.18502/ijrm.v17i5.4604 |
work_keys_str_mv | AT talebimehrdad isthereanyrelationshipbetweenmutationincps1geneandpregnancyloss AT yahyavahidimehrjardimohammad isthereanyrelationshipbetweenmutationincps1geneandpregnancyloss AT kalhorkambiz isthereanyrelationshipbetweenmutationincps1geneandpregnancyloss AT dehghanimohammadreza isthereanyrelationshipbetweenmutationincps1geneandpregnancyloss |